Indeed, a number of studies can be found describing the improvement of anticancer effects of distinct agents by Dnmt inhibitors in castration‐resistant PCa (Festuccia et al., 2009; Sonpavde et al., 2008). The gene discussed is DNMT1; the disease is posterior cortical atrophy.